Drug Profile
HX 1920
Latest Information Update: 31 May 1995
Price :
$50
*
At a glance
- Originator Asahi Kasei
- Class Anti-inflammatories; Antiallergics; Antineoplastics; Radioprotectives
- Mechanism of Action Hyaluronidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Radiation injuries
Most Recent Events
- 23 May 1995 Discontinued-Preclinical for Radiation injuries (Prevention)/Radioprotection in Japan (Unknown route)